OA10976A - Pharmaceutical compositions of corticotropin releasing hormone antagonists - Google Patents

Pharmaceutical compositions of corticotropin releasing hormone antagonists Download PDF

Info

Publication number
OA10976A
OA10976A OA9900034A OA9900034A OA10976A OA 10976 A OA10976 A OA 10976A OA 9900034 A OA9900034 A OA 9900034A OA 9900034 A OA9900034 A OA 9900034A OA 10976 A OA10976 A OA 10976A
Authority
OA
OAPI
Prior art keywords
dimethyl
phenoxy
ethyl
trimethyl
propoxy
Prior art date
Application number
OA9900034A
Other languages
English (en)
French (fr)
Inventor
Chen Yuhpyng Liang
Fossa Anthony Andrea
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of OA10976A publication Critical patent/OA10976A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
OA9900034A 1998-02-17 1999-02-16 Pharmaceutical compositions of corticotropin releasing hormone antagonists OA10976A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7493498P 1998-02-17 1998-02-17

Publications (1)

Publication Number Publication Date
OA10976A true OA10976A (en) 2001-11-05

Family

ID=22122537

Family Applications (1)

Application Number Title Priority Date Filing Date
OA9900034A OA10976A (en) 1998-02-17 1999-02-16 Pharmaceutical compositions of corticotropin releasing hormone antagonists

Country Status (28)

Country Link
US (1) US6043260A (id)
EP (1) EP0951906A1 (id)
JP (1) JPH11292766A (id)
KR (1) KR19990072616A (id)
CN (1) CN1231176A (id)
AP (1) AP9901464A0 (id)
AR (1) AR017723A1 (id)
AU (1) AU1732999A (id)
BG (1) BG103180A (id)
BR (1) BR9900653A (id)
CA (1) CA2262252C (id)
EA (1) EA199900124A3 (id)
GT (1) GT199900015A (id)
HR (1) HRP990054A2 (id)
HU (1) HUP9900386A3 (id)
ID (1) ID23218A (id)
IL (1) IL128531A0 (id)
IS (1) IS4975A (id)
MA (1) MA26608A1 (id)
NO (1) NO990722L (id)
OA (1) OA10976A (id)
PA (1) PA8467401A1 (id)
PE (1) PE20000266A1 (id)
PL (1) PL331507A1 (id)
SG (1) SG81261A1 (id)
TN (1) TNSN99024A1 (id)
TR (1) TR199900328A2 (id)
ZA (1) ZA991220B (id)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6403599B1 (en) 1995-11-08 2002-06-11 Pfizer Inc Corticotropin releasing factor antagonists
US7125880B1 (en) 1995-06-06 2006-10-24 Pfizer Inc. Corticotropin releasing factor antagonists
US6956047B1 (en) 1995-06-06 2005-10-18 Pfizer Inc. Corticotropin releasing factor antagonists
US6387894B1 (en) * 1999-06-11 2002-05-14 Pfizer Inc. Use of CRF antagonists and renin-angiotensin system inhibitors
JP2003509478A (ja) * 1999-09-21 2003-03-11 エモリー・ユニバーシティ 血小板関連障害を処置する方法および組成物
CA2397633A1 (en) * 2000-01-18 2001-07-26 Pfizer Products Inc. Corticotropin releasing factor antagonists
GB0027410D0 (en) * 2000-11-09 2000-12-27 Pfizer Ltd Mutual prodrug of amlodipine and atorvastatin
US6737430B2 (en) 2000-11-09 2004-05-18 Pfizer, Inc. Mutual prodrug of amlodipine and atorvastatin
US6992087B2 (en) 2001-11-21 2006-01-31 Pfizer Inc Substituted aryl 1,4-pyrazine derivatives
WO2003072107A1 (en) 2002-02-22 2003-09-04 Pharmacia & Upjohn Company Substituted pyrimidinones and pyrimidinthiones
AU2003220190A1 (en) * 2002-03-13 2003-09-29 Pharmacia & Upjohn Company Llc Pyrazolo(1,5-a)pyridine derivatives as neurotransmitter modulators
BR0309551A (pt) * 2002-04-26 2005-02-09 Upjohn Co Derivados substituìdos de pirazina
EP1539736A1 (en) * 2002-09-12 2005-06-15 Pharmacia & Upjohn Company LLC Substituted 1,4-pyrazine derivatives
AR041470A1 (es) * 2002-10-17 2005-05-18 Upjohn Co Compuestos de pirrolo (1,2 - b) piridazina y sus usos
AU2003278542A1 (en) * 2002-11-21 2004-06-15 Pharmacia & Upjohn Company Llc Pyrazine compounds as crf modulators
MXPA05011387A (es) * 2003-04-23 2005-12-01 Pharmacia & Upjohn Co Llc Pirimidinonas y pirimidinotionas sustituidas.
JP2006525309A (ja) * 2003-05-07 2006-11-09 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー ピロロ（１，２−ｂ）ピリダジン化合物、ならびにＣＲＦ−１受容体拮抗薬としてのその使用
EP1625115A1 (en) * 2003-05-09 2006-02-15 Pharmacia & Upjohn Company LLC Substituted pyrimidine derivatives
CA2525195A1 (en) * 2003-05-09 2004-11-18 Pharmacia & Upjohn Company Llc Pyrazinones as crf1 receptor antagonists for the treatment of cns disorders
MXPA05012082A (es) * 2003-05-09 2006-02-22 Pharmacia & Upjohn Co Llc Compuestos como antagonistas del receptor crf1.
WO2005089639A2 (en) * 2004-03-16 2005-09-29 Talarico M D Matthew T Method for vascular dysregulation
US20060211710A1 (en) * 2005-03-17 2006-09-21 Pfizer Inc Substituted aryl 1,4-pyrazine derivatives
US8338441B2 (en) * 2009-05-15 2012-12-25 Gilead Sciences, Inc. Inhibitors of human immunodeficiency virus replication

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW574214B (en) * 1994-06-08 2004-02-01 Pfizer Corticotropin releasing factor antagonists
US6403599B1 (en) * 1995-11-08 2002-06-11 Pfizer Inc Corticotropin releasing factor antagonists
EP0795327A1 (en) * 1996-03-13 1997-09-17 Pfizer Inc. Use of Amlodipine for the treatment and prophylaxis of congestive cardiac failure of non-ischaemic origin

Also Published As

Publication number Publication date
IL128531A0 (en) 2000-01-31
BR9900653A (pt) 2000-10-17
AP9901464A0 (en) 1999-03-31
PL331507A1 (en) 1999-08-30
HUP9900386A3 (en) 1999-12-28
US6043260A (en) 2000-03-28
SG81261A1 (en) 2001-06-19
IS4975A (is) 1999-08-18
MA26608A1 (fr) 2004-12-20
NO990722D0 (no) 1999-02-16
AU1732999A (en) 1999-09-02
GT199900015A (es) 2000-07-26
CN1231176A (zh) 1999-10-13
CA2262252A1 (en) 1999-08-17
ZA991220B (en) 2000-08-16
EA199900124A2 (ru) 1999-08-26
TNSN99024A1 (fr) 2005-11-10
NO990722L (no) 1999-08-18
HUP9900386A2 (hu) 1999-11-29
HU9900386D0 (en) 1999-04-28
BG103180A (bg) 1999-09-30
PE20000266A1 (es) 2000-04-07
JPH11292766A (ja) 1999-10-26
ID23218A (id) 2000-03-30
AR017723A1 (es) 2001-09-12
EA199900124A3 (ru) 1999-12-29
CA2262252C (en) 2006-01-10
TR199900328A2 (xx) 1999-10-21
EP0951906A1 (en) 1999-10-27
KR19990072616A (ko) 1999-09-27
PA8467401A1 (es) 2000-09-29
HRP990054A2 (en) 2000-02-29

Similar Documents

Publication Publication Date Title
CA2262252C (en) Method of treating heart failure
US5527819A (en) Inhibitors of HIV reverse transcriptase
EP0233461B2 (en) 4,5,6-Substituted-2-pyrimidinamines
TWI458719B (zh) 非核苷反轉錄酶抑制劑
EP1399423B1 (de) Anthranilsäureamide mit heteroarylsulfonyl-seitenkette und ihre verwendung als antiarrhythmische wirkstoffe
JPS62281858A (ja) ピペリジン誘導体及びその類縁誘導体
DE60313350T2 (de) Pyrimidin-2,4-dion-derivate als matrix-metalloproteinase-hemmer
DE102004050196A1 (de) Substituierte 2-Pyridon-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament
US20120309786A1 (en) 3-amino-pyridine derivatives for the treatment of metabolic disorders
JP2003531856A (ja) リン酸輸送阻害剤
TWI435871B (zh) 苯基咪唑化合物
JP2010522168A (ja) 鉱質コルチコイドレセプターモジュレータ
TW445251B (en) Substituted indanylidineacetylguanidines, process for their preparation, their use as medicaments or diagnostic and medicaments containing them
JPH0699309B2 (ja) 離脱症候群関連障害治療用医薬製品
DE60221152T2 (de) Diaryl-1,2,4-triazolderivate als hochselektive cyclooxygenase-2-inhibitoren
US5534532A (en) Aliphatic amino bis-aryl squalene synthase inhibitors
JPH072737B2 (ja) ５−リポキシゲナ−ゼ経路の抑制
WO2007085203A1 (fr) Nouveaux composés azahétérocycliques pentabasiques et utilisation de ces derniers dans le traitement de maladies liées au vieillissement des protéines
CZ51399A3 (cs) Farmaceutická kompozice a kit
JP2002155060A (ja) イミダゾール化合物及びその用途
KR101128372B1 (ko) 1ｈ-피리딘-2-온 유도체
JPS635082A (ja) ベンズイミダゾ−ル、その製法および胃酸分泌抑制剤としての処方物
JPH0770083A (ja) イミダゾール誘導体を有効成分とする血圧降下剤
KR20060098907A (ko) 피롤로[2,3-ｄ]피리다진 유도체 및 그의 제조방법
JPH02142797A (ja) チアゾロトリアゾール化合物